Latest Pancreatic disease Stories
In the latest clinical trial for a technique to detect pancreatic cancer, researchers found they could differentiate cells that are cancerous from those that are benign, pre-cancerous, or even early stage indicators called mucinous cystic lesions.
Bethesda, MD (February 10, 2009) â€“ Digestive, liver and pancreatic diseases result in more than 100 million outpatient visits and 13 million hospitalizations annually at a cost of $141.8 billion.
US-based pharmaceutical company Digestive Care has completed the submission of the new drug application for Pancrecarb, used in the treatment of exocrine pancreatic insufficiency, to the FDA.
BETHLEHEM, Pa., Oct. 27 /PRNewswire/ -- Digestive Care, Inc. (DCI) announced today that it has completed the submission of the New Drug Application ("NDA") for PANCRECARB(R) (pancrelipase), used in the treatment of Exocrine Pancreatic Insufficiency ("EPI"), to the U.S.
Scientists hope that a new development, which allows them to create pigs that develop cystic fibrosis in the same way the people do, will give them new insight into fighting the disease.
By CAROLINE INNES LIVERPOOL doctors are to pioneer new treatments for one of the most deadly forms of cancer after landing pounds 5m worth of funding.
By Kleven, Daniel T McCudden, Christopher R; Willis, Monte S Cystic fibrosis (CF) is the most common lethal genetic disease in Caucasians, occurring in 1/2,500 births.12 In its most common form, CF manifests as progressive lung dysfunction, pancreatic insufficiency, and intestinal disease (see Figure 1).
By Covarelli, Piero Badolato, Marco; Boselli, Carlo; Noya, Giuseppe; Cristofani, Roberto; Mosca, Stefano; Tei, Francesco To the Editor: We report a case of recurrent gastric bleeding in a 73-year-old man with splenic vein thrombosis after a necrotizing pancreatitis palliated with surgery but treated with splenic artery embolization.
Mayo Clinic researchers have found the risk of developing pancreatic cancer at a young age (under 60) to be twice as high for people who carry a mutation of the gene that causes cystic fibrosis, compared to noncarriers. Results of a pilot and follow-up study were reported Oct. 14, 2005, online in the journal Gut.
- Emitting flashes of light; glittering.